Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems

“Schizophrenia is arguably the worst disease affecting mankind, even AIDS not excepted”. Since this statement in 1988 (Editors, 1988), schizophrenia still remains a major challenge to medicine, with up to 60% of patients not responding adequately to treatment despite the relatively large arsenal of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Soares, Bruno Lobão, Maia-de-Oliveira, Joao Paulo, Baker, Glen B., Hallak, Jaime E.C., Dursun, Serdar M.
Formato: article
Idioma:eng
Publicado em: Elsevier
Assuntos:
Endereço do item:https://repositorio.ufrn.br/jspui/handle/123456789/25459
https://doi.org/10.1016/j.schres.2014.08.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
id ri-123456789-25459
record_format dspace
spelling ri-123456789-254592021-11-11T19:09:08Z Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems Soares, Bruno Lobão Maia-de-Oliveira, Joao Paulo Baker, Glen B. Hallak, Jaime E.C. Dursun, Serdar M. Sodium nitroprusside “Schizophrenia is arguably the worst disease affecting mankind, even AIDS not excepted”. Since this statement in 1988 (Editors, 1988), schizophrenia still remains a major challenge to medicine, with up to 60% of patients not responding adequately to treatment despite the relatively large arsenal of antipsychotics currently available. By modulating the nitric oxide (NO) pathway, a new paradigm for schizophrenia treatment apparently involving modulation of nitric oxide (NO) has been proposed (Oliveira et al., 2011). 2018-06-19T13:56:39Z 2018-06-19T13:56:39Z 2014-11 article SOARES, Bruno Lobão et al. Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems. Schizophrenia Research, v. 14, p. 456-456, 2014. Disponível em: <http://www.schres-journal.com/article/S0920-9964(14)00456-3/abstract>. Acesso em: 27 mar. 2018. 0920-9964 https://repositorio.ufrn.br/jspui/handle/123456789/25459 https://doi.org/10.1016/j.schres.2014.08.020 eng Acesso Aberto application/pdf Elsevier
institution Repositório Institucional
collection RI - UFRN
language eng
topic Sodium nitroprusside
spellingShingle Sodium nitroprusside
Soares, Bruno Lobão
Maia-de-Oliveira, Joao Paulo
Baker, Glen B.
Hallak, Jaime E.C.
Dursun, Serdar M.
Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
description “Schizophrenia is arguably the worst disease affecting mankind, even AIDS not excepted”. Since this statement in 1988 (Editors, 1988), schizophrenia still remains a major challenge to medicine, with up to 60% of patients not responding adequately to treatment despite the relatively large arsenal of antipsychotics currently available. By modulating the nitric oxide (NO) pathway, a new paradigm for schizophrenia treatment apparently involving modulation of nitric oxide (NO) has been proposed (Oliveira et al., 2011).
format article
author Soares, Bruno Lobão
Maia-de-Oliveira, Joao Paulo
Baker, Glen B.
Hallak, Jaime E.C.
Dursun, Serdar M.
author_facet Soares, Bruno Lobão
Maia-de-Oliveira, Joao Paulo
Baker, Glen B.
Hallak, Jaime E.C.
Dursun, Serdar M.
author_sort Soares, Bruno Lobão
title Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
title_short Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
title_full Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
title_fullStr Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
title_full_unstemmed Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
title_sort sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
publisher Elsevier
publishDate 2018
url https://repositorio.ufrn.br/jspui/handle/123456789/25459
https://doi.org/10.1016/j.schres.2014.08.020
work_keys_str_mv AT soaresbrunolobao sodiumnitroprussideanitricoxidedonorfornoveltreatmentofschizophreniamayalsomodulatedopaminergicsystems
AT maiadeoliveirajoaopaulo sodiumnitroprussideanitricoxidedonorfornoveltreatmentofschizophreniamayalsomodulatedopaminergicsystems
AT bakerglenb sodiumnitroprussideanitricoxidedonorfornoveltreatmentofschizophreniamayalsomodulatedopaminergicsystems
AT hallakjaimeec sodiumnitroprussideanitricoxidedonorfornoveltreatmentofschizophreniamayalsomodulatedopaminergicsystems
AT dursunserdarm sodiumnitroprussideanitricoxidedonorfornoveltreatmentofschizophreniamayalsomodulatedopaminergicsystems
_version_ 1773967044263280640